Regulatory Filings • Aug 1, 2017
Regulatory Filings
Open in ViewerOpens in native device viewer
****
Clustering is a central issue for machine learning and artificial intelligence. Clustering represents a procedure for arranging objects in groups (clusters) and assigning labels to clusters to make them meaningful. Computers are capable, throughout a machine-learning programme, to cluster users according to their behaviour, and find appropriate labels to these clusters. As the number of users increases, and the quantity of information by user decreases, users become more diverse and the problem is more difficult.
For that reason, Sailendra decided to develop a new clustering algorithm capable of managing this problematic using subjective logic, itself is an extension of probabilistic logic.
At this conference, Charif HAYDAR unveiled a new clustering algorithm based on the mutual vote, which adjusts itself automatically to the dataset, demands a minimum of parameterizing, and is able to detect clusters with different density at a time.
This algorithm, named MUTUAL VOTES, was tested and compared to many existing clustering algorithms on clustering users in a recommender system context. And this comparison was decisive: the algorithm adjusts itself automatically to the typology of the data in high dimensional spaces, and needs no parameterization.
MUTUAL VOTES' performance was demonstrated using a real dataset:
for sales of the company J.Milliet, a distributor of beverages to professionals in the restaurant sector and the retail market. The performances of Sailendra's algorithm was then compared to other clustering algorithms in terms of labelling clusters quality and prediction of users' purchases. Results demonstrated the advantages of the algorithm developed by Sailendra, especially in terms of prediction.
The algorithms developed in the framework of UMAP 2017 will make it possible to further enhance the recommendations proposed by the Sailendra system.
This innovation will in particular improve the effectiveness of the technological offering developed by Sailendra and enable it to offer fine-tuned and automatic clustering to its customers in order to:
For Régis LHOSTE, Chair and Founder of Sailendra: "We are very proud that the research work of Charif HAYDAR and Anne BOYER was recognized by the jury of UMAP 2017, a leading scientific conference. For us, this represents a very prestigious recognition by the scientific community that will contribute significantly to the notoriety of the research carried out at Sailendra. The data collected by or for companies has today become a major priority. The information, and all unexploited information within the enormous volumes of data, has become for these companies a major factor for competitiveness and innovation. Today we have demonstrated that our new algorithm has surpassed existing algorithms in terms of both precision and prediction; These results are encouraging and we are currently testing our algorithm on other types of data, in particular larger datasets in order to demonstrate its scalability.
SAILENDRA, a 70%-owned subsidiary of PHARMAGEST Group, is a young French company originating from the world of research. It combines complementary high-level areas of expertise. It designs and develops artificial intelligence-based purchase optimisation solutions for e-commerce, the healthcare sector and e-learning. Sailendra proposes in particular Sailsense, a behavioural analysis solution capable of proposing personalized recommendations for e-commerce to boost sales and customer retention.
Pharmagest Group is the French pharmacy information technology leader, with a 43.5% market share and nearly 900 employees. The Group's strategy is based on a core business of improving healthcare through information technology innovation and developing two priority areas: 1/ Services and technologies for healthcare professionals, with a focus on assisting pharmacies in the area of patient medication compliance; and 2/ technologies for improving the efficacy of healthcare systems.
To roll out that strategy, Pharmagest Group has developed specialised businesses, including pharmacy IT, e-Health solutions, solutions for healthcare professionals, solutions for pharmaceutical laboratories, connected health devices and apps, and a sales financing marketplace.
These businesses are now divided into four divisions: The Solutions for Pharmacy Division – Europe, the Solutions for Health and Social Care Facilities Division, the Solutions for e-Health Division, and the FinTech Division.
Listed on Euronext Paris™ - Compartment B Indices: CAC ® SMALL and CAC ® All-Tradable par inclusion Eligible for the Long-Only Deferred Settlement Service (SRD) ISIN: FR 0012882389 – Reuters: PHA.PA – Bloomberg: - PMGI FP
For all the latest news go to www.pharmagest.com
FIN'EXTENSO – Isabelle APRILE Tel. +33 (0)1 39 97 61 22 - [email protected]
Régis LHOSTE – Chair Tel.: +33 (0)3 72 47 03 38 - [email protected]
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.